87 results
Page 2 of 5
424B5
wcsp8ap
26 Jul 23
Prospectus supplement for primary offering
4:24pm
424B5
j212h
24 Jul 23
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
xxi0ihkacgq5t5ff
11 May 23
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.1
nhl4zjzc sz
22 Dec 22
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results
9:11am
424B5
oth902b w3k
22 Dec 22
Prospectus supplement for primary offering
6:43am
8-K
EX-99.1
3y1i sdva4eew
25 Oct 22
NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use
9:19am
8-K
EX-99.1
ltzsvyvzmq4dhw np450
14 Sep 22
Regulation FD Disclosure
8:30am
8-K
EX-99.1
jebgx4o
11 Aug 22
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:49pm
8-K
EX-99.1
vwhgynh4ghqsjn6hz nf
3 Aug 22
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
9:34am
8-K
EX-99.1
hr1 ocdif
2 Jun 22
NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders
4:05pm
8-K
EX-99.1
v2xevkyc0zii4i0oa1w
16 May 22
NeuroOne Provides Evo® sEEG Update
4:38pm
8-K
EX-99.1
6w397h3 aq7n5iw4f
12 May 22
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:17pm
8-K
EX-99.1
bwfhwh uzgbq10wve
14 Feb 22
NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:10pm